These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Lu HD; Zhao HQ; Wang K; Lv LL Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044 [TBL] [Abstract][Full Text] [Related]
3. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation. Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813 [TBL] [Abstract][Full Text] [Related]
5. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
6. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Fan W; Yan W; Xu Z; Ni H Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934 [TBL] [Abstract][Full Text] [Related]
7. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers. Umerska A; Paluch KJ; Inkielewicz-Stępniak I; Santos-Martinez MJ; Corrigan OI; Medina C; Tajber L Int J Pharm; 2012 Oct; 436(1-2):75-87. PubMed ID: 22814226 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753 [TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
10. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery. Almalik A; Day PJ; Tirelli N Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105 [TBL] [Abstract][Full Text] [Related]
11. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles. Umerska A; Corrigan OI; Tajber L Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822 [TBL] [Abstract][Full Text] [Related]
12. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination. Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553 [TBL] [Abstract][Full Text] [Related]
14. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. Liu Z; Jiao Y; Liu F; Zhang Z J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Duceppe N; Tabrizian M Biomaterials; 2009 May; 30(13):2625-31. PubMed ID: 19201022 [TBL] [Abstract][Full Text] [Related]
16. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems. Liu P; Zhao X Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874 [TBL] [Abstract][Full Text] [Related]
17. Improving the osteogenesis of rat mesenchymal stem cells by chitosan-based-microRNA nanoparticles. Wu G; Feng C; Hui G; Wang Z; Tan J; Luo L; Xue P; Wang Q; Chen X Carbohydr Polym; 2016 Mar; 138():49-58. PubMed ID: 26794737 [TBL] [Abstract][Full Text] [Related]
18. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity. Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155 [TBL] [Abstract][Full Text] [Related]
19. Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery. Zohri M; Akbari Javar H; Gazori T; Khoshayand MR; Aghaee-Bakhtiari SH; Ghahremani MH Int J Nanomedicine; 2020; 15():8345-8356. PubMed ID: 33154637 [TBL] [Abstract][Full Text] [Related]
20. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs. Abdel-Hafez SM; Hathout RM; Sammour OA Int J Biol Macromol; 2014 Mar; 64():334-40. PubMed ID: 24355618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]